Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (KCT0012799) titled 'A Study to Compare the Safety and Zinc Exposure of Tegoprazan Hemi Zinc Chloride and Zinkistin Capsules in Healthy Adults' on Oct. 20.
Study Type: Interventional Study
Study Design:
Primary Purpose : Other(This study aims to evaluate the safety and zinc exposure in healthy adult subjects, using Zincstin Capsule (Pharmbio Korea Co., Ltd.) as the reference drug and tegoprazan hemizinc chloride (Inist ST C), Intervention Model : Cross-over, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: The Catholic University of Korea, Seoul St. Mary's Hospital
Condition:
Factors influencing health status and contact wit...